Evidence map›Paper›PMID 41438531›Full record

ReviewIndian journal of thoracic and cardiovascular surgery2026

Transcatheter mitral and tricuspid therapy: outcomes in female patients.

Gry Dahle

Abstract readReview
In one paragraph

Review in Indian journal of thoracic and cardiovascular surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Gry DahleDepartment of Cardiothoracic Surgery, Oslo University Hospital, Sognsvannsveien 20, Oslo, 0372 Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Development of mitral and tricuspid devices has exploded, although the number of procedures is still limited. Women are under-represented in clinical trials, and in many trials, outcomes are not specified for sex. In mitral and tricuspid trials, the sex distribution is more even than in transcatheter aortic valve implantation (TAVI) trials. In these trials, in general, females are older, have more bleeding complications, and have less kidney injury than men. Procedural results are good. Long-term observation is still not available because of short observation time. In tricuspid procedures, other factors than device success play a role, like right heart failure, pulmonary hypertension, and atrial fibrillation. We should, for the future, focus more on differences in outcome between men and women to better customize treatment options. Graphical Abstract: Transcatheter mitral and tricuspid interventions, outcomes in women. Generated by AI.

Indexed as

Mitral and tricuspid devicesMitral and tricuspid trialsSex distribution

Identifiers

PMID41438531
PMCPMC12719359

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.